New chromatin‑based analysis of 1,563 AML samples reveals 16 epigenomic subgroups that improve prognostic accuracy and highlight unexpected drug sensitivities. The post Epigenomic Analysis Uncovers New AML Subgroups and Drug Sensitivities appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
This common pesticide may be quietly wiping out future...
Ipsen to acquire Memo Therapeutics in deal worth more...
GSK, Hansoh ADC extends survival in lung cancer study
ARPA-H puts $160M into bespoke drug therapies;...
Bausch + Lomb gives up on glaucoma eye drop hopeful...
ARPA-H awards up to $160M to scientists developing...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.